|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||0.00 - 0.00|
|52 Week Range|
|PE Ratio (TTM)||43.91|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Fuse Medical, Inc., (FZMD), (“Fuse” or the “Company”), announced that it has filed its quarterly report on Form 10-Q for the first quarter ended March 31, 2018, with the United States Securities and Exchange Commission, (the “SEC”) on Tuesday, May 15, 2018. Christopher C. Reeg, Chief Executive Officer, commented, “We are pleased to report our first quarter of 2018 results with increases of approximately 7% and 14%, for net revenue and gross profit, respectively, compared to the same period one year ago. With the successful completion of our acquisition of CPM Medical Consultants, LLC, reflected positively in our 2017 Annual Report on Form 10-K filing, all of us at Fuse are very excited about what this partnership will mean for our next phase of growth, as well as the benefits it offers our customers.
Fuse Medical, Inc., , , announced the appointment of Montgomery, Coscia, Greilich, LLP, , headquarter in Plano, Texas, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2017.
Fuse Medical, Inc., , , announced the completion of the acquisition of CPM Medical Consultants, LLC , a privately-owned nationwide distributor of medical device implants and biologics, .
Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against Fuse Medical, Inc.
Fuse Medical, Inc., , , announced today that it signed a definitive purchase agreement to acquire CPM Medical Consultants, LLC , a privately-owned nationwide distributor of medical device implants and biologics.
Fuse Medical, Inc. announced today that it signed a non-binding Letter of Intent to purchase all of the outstanding membership units of CPM Medical Consultants, LLC , a privately-owned national distributor of medical device implants and biologics.